|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/28 | (2006.01) |
| A61P 5/48 | (2006.01) | ||
| A61K 33/30 | (2006.01) | ||
| A61K 47/10 | (2017.01) |
| (11) | Patento numeris | 3554534 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17832941.3 |
| Europos patento paraiškos padavimo data | 2017-12-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-10-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-06-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/083013 |
| Data | 2017-12-15 |
| (87) | Numeris | WO 2018/109162 |
| Data | 2018-06-21 |
| (30) | Numeris | Data | Šalis |
| 16204688 | 2016-12-16 | EP |
| (72) |
NORRMAN, Mathias , DK
HOSTRUP, Susanne , DK
STEENSGAARD, Dorte, Bjerre , DK
STRAUSS, Holger, Martin , DK
HANSEN, Rosa, Rebecca, Erritzøe , DK
HAVELUND, Svend , DK
SCHLEIN, Morten , DK
PEDERSEN, Jesper, Søndergaard , DK
|
| (73) |
Novo Nordisk A/S ,
Novo Allé, 2880 Bagsværd,
DK
|
| (54) | INSULIN CONTAINING PHARMACEUTICAL COMPOSITIONS |
| INSULIN CONTAINING PHARMACEUTICAL COMPOSITIONS |